This study contributes to the existing literature by identifying THBS1 and the JAK2/STAT3 pathway as promising molecular targets for therapeutic intervention in RILI-associated fibrosis, offering a feasible mechanistic basis for future antifibrotic strategies. The gene discussed is STAT3; the disease is fibrosis.